Longevity Health Holdings Announces Strategic Investment and CEO Appointment, Sets Sights on Acquisition-Driven Growth

Key Highlights for Investors

• Appointment of New Chairman and CEO: Ram Ajjarapu has been appointed as Chairman and Chief Executive Officer of Longevity Health Holdings, Inc. (OTCQB: XAGE), effective March 16, 2026. The leadership transition is seen as a pivotal move to drive the company’s next growth phase.
• Strategic Investment by CEO: In conjunction with his appointment, Mr. Ajjarapu made a significant personal investment in the company via a private placement, providing tangible alignment between management and shareholders.
• Acquisition Platform Strategy: The company is shifting its growth strategy to focus on disciplined, value-accretive acquisitions aimed at expanding operations, accelerating earnings, and enhancing shareholder value while maintaining prudent capital management.
• Leadership Transition: Outgoing CEO Rajiv Shukla will remain as an advisor to ensure continuity and retain a significant equity stake in the company, which should reassure stakeholders during the transition.

Detailed Developments

Longevity Health Holdings, Inc. has announced a transformative leadership change and a new strategic direction that could have significant implications for its future performance and share value.

The Board of Directors has appointed Ram Ajjarapu as Chairman and CEO, effective March 16, 2026. Ajjarapu brings a well-established track record in scaling businesses and executing value-creating transactions. Outgoing CEO and Chairman, Rajiv Shukla, expressed confidence in Ajjarapu’s ability to lead Longevity’s acquisition-driven growth strategy as a public company.

As a sign of commitment, Mr. Ajjarapu has invested in Longevity through a private placement, acquiring a substantial equity position. This investment not only provides capital for growth but also closely aligns Ajjarapu’s interests with those of shareholders, sending a strong signal of management’s confidence in the company’s potential. Shukla will stay on as an advisor and remain a significant shareholder, providing stability during the transition.

CEO Profile: Ram Ajjarapu

At 57, Mr. Ajjarapu brings vast experience across technology, business management, and finance. His recent leadership roles include serving as CEO of RA Capital Funding LLC since January 2023, CEO of STP Brokerage Inc. since March 2021, and CEO of Especially Yours Inc. since July 2025. Notably, he was also CEO of Ashley Stewart Inc. (March–October 2024) and spent nearly three decades as President and CEO of Global Information Technology (GIT), a \$50 million revenue company serving Fortune 100 clients. Ajjarapu’s background includes founding and co-founding several successful ventures. He holds a bachelor’s in Electronics and Communication Engineering and an MBA from the University of South Florida.

Company Overview and Strategy Shift

Longevity Health Holdings is a bio-aesthetics company focusing on longevity and healthy aging, with two proprietary cosmetic product lines: Elevai Exosomes™ and Carmell Secretome™ for skin and hair health. These products are sold in the U.S. through business-to-business, direct-to-consumer, and distributor channels. The new strategy marks a significant evolution for the company, as it aims to build an acquisition platform to drive growth, expand its operations, and enhance profitability.

Ajjarapu’s leadership is expected to usher in disciplined, value-accretive acquisitions that will be accretive to earnings and long-term shareholder value, while maintaining a prudent capital structure. This could be a catalyst for share price re-rating if successful.

Forward-Looking Statements and Risks

Management cautions that forward-looking statements, including the ability to execute the acquisition strategy, integrate businesses, and realize expected synergies, involve significant risks and uncertainties. These include challenges in raising additional capital, potential dilution from future financings, integration risks, and competition. Investors are urged to review the “Risk Factors” section in the company’s filings with the SEC.

Shareholder Impact and Price Sensitivity

• Leadership Change: A new CEO with a proven track record and a significant personal investment typically signals confidence and could drive positive investor sentiment.
• Strategic Shift: Moving towards an acquisition-driven model may accelerate growth and profitability, but also introduces execution and integration risks.
• Financial Alignment: The CEO’s investment aligns management’s interests with shareholders, which is a positive governance signal.
• Potential Volatility: The strategic changes and leadership transition are material events that may influence share price volatility in the near term.

Contact

For further inquiries, contact Bryan Cassaday at [email protected].

Disclaimer: This article contains forward-looking statements based on management’s current expectations and projections. Actual results may differ materially due to risks and uncertainties. Readers should not rely exclusively on these statements for investment decisions. Always consult the company’s official filings with the SEC and seek professional advice before acting on this information.

View Longevity Health Holdings, Inc. Historical chart here